Neuropeptide Y-mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by σ1 receptor antagonists
- 4 May 1998
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 31 (1) , 27-36
- https://doi.org/10.1016/s0920-9964(98)00002-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inverse agonism: pharmacological curiosity or potential therapeutic strategy?Published by Elsevier ,2000
- Regulation of [3H]dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptorsSchizophrenia Research, 1996
- Piperidinyltetralin .sigma. LigandsJournal of Medicinal Chemistry, 1994
- Neuropeptide Y-Related Peptides and their Receptors--Are the Receptors Potential Therapeutic Drug Targets?Annual Review of Pharmacology and Toxicology, 1993
- Sigma receptors are associated with cortical limbic areas in the primate brainSynapse, 1992
- Alterations in phencyclidine and sigma binding sites in schizophrenic brains: Effects of disease process and neuroleptic medicationSchizophrenia Research, 1991
- Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in ratsNeuropharmacology, 1991
- Neuropeptide Y-like immunoreactivity in schizophreniaSchizophrenia Research, 1990
- Motor effects of two sigma ligands mediated by nigrostriatal dopamine neuronsSynapse, 1988
- The Sigma ReceptorClinical Neuropharmacology, 1988